Autism Drug Effectiveness in Comorbidities

The three autism comorbidities that I have chosen to investigate are asthma, high cholesterol and various types of seizure.

 
Phase 1

The first phase is the easy one.  I just need to see if my autism drugs are proven to be effective in the each comorbidity.  The results really surprised me.

With the exception of bumetanide and asthma, there is a perfect overlap.  Even more surprising, is that another loop diuretic, called furosemide, which is very similar to bumetanide, has been showed to be effective in asthma when given in the inhaled form.

In the case of cholesterol, I am looking at elevated levels in cardiology.  The use of bumetanide in people with heart problems associated with high cholesterol is to reduce blood pressure (anti-hypertensive).
 

 
You can check use of my autism drugs in each comorbidity using Google, or just look at the links I selected below.

 
Asthma/COPD

NAC improves effectiveness of the conventional corticosteroid therapy, particularly in hard to treat cases like current or past smokers. In COPD a severe form of asthma, read:  The role for N-acetylcysteine in the management of COPD

Do statins improve outcomesin patients with asthma on inhaled corticosteroid therapy?

Effect of inhaled furosemide and bumetanide on adenosine5'-monophosphate- and sodium metabisulfite-induced bronchoconstriction in asthmatic subjects

  
High Cholesterol (cardiac treatment)

NAC raises your good HDL cholesterol level, so lowering your overall cholesterol risk factor.

Dose-Related Increase of HDL-cholesterol Levels after N-acetylcysteine in Man

Statins were primarily developed to lower cholesterol as part of cardiac treatment.
 
Bumetanide is a loop diuretic and anti-hypertensive drug primarily marketed as a cardiac drug.

 
Seizures

 Glutathione peroxidase deficiency and childhood seizures

Treatment off our siblings with progressive myoclonus epilepsy of the Unverricht-Lundborg type with N-acetylcysteine
 
Role of Oxidative Stress in Refractory Epilepsy: Evidencein Patients and Experimental Models
 (then click for full version)

Can Statins Lower the Risk for Epilepsy?

Blocking seizures with the diuretic Bumetanide: Promises and pitfalls

 

Phase 2

The second phase involves understanding each comorbidity and seeing if any of their established treatments can be effective in treating autism.

This will also produce some surprises in the following posts.






 

Comments

Post a Comment

Popular posts from this blog

mTOR – Indirect inhibition, the Holy Grail for Life Extension and Perhaps Some Autism

Image
  Not cheap at about $1,000 for just 140mg Life extension may come as a surprise, but it is interesting because it is well studied and, in mice at least, easy to measure.  Most research into mTOR relates to cancer, but this is a very complex condition. With various feedback loops it means that sometimes the actual effect is the opposite of what was predicted.  For example, a substance that can help prevent cancer can actually become harmful later and promote its growth. Direct inhibition of mTOR with Everolimus and similar drugs (variants/analogs of Rapamycin , all called Rapalogs) has not been as successful as hoped in cancer research.  Trials of direct inhibition of mTOR will shortly start in one rare single gene type of autism ( TSC ).  The drugs are so expensive that many providers do not want to pay for them. As you will see mTOR is just one process in a cloud of interrelated processes.   Almost everything has a role/effect:- growth factors, cytokines,...
Read more

Zinc, Hedgehog Signaling, Shank2/3, NMDA/AMPA Inactivation and Autism

Image
I am gradually tying up the loose ends in this blog. Today several issues are dealt with that are all connected by zinc. Some are extremely complicated and I will skip over the details. Not that kind of hedgehog 1.      In those rather complicated graphics in the literature that explain signaling pathways, you may have noticed something called hedgehog signaling. This is a basic pathway present in all bilaterians - creatures with a head and tail/feet and a left and right. So flies, yes; but jelly fish, no.   In autism there is excessive hedgehog signaling.   Zinc deficiency is linked to activation of the hedgehog signaling pathway 2.      One of the commonly used models of autism is called Shank3; there is another one called Shank2.   Shank proteins are scaffold proteins that connect neurotransmitter receptors and ion channels to the actin cytoskeleton and G-protein-coupled signaling pathways.   Mutations in these genes are ass...
Read more

Bravo Monty! Academic results in Autism

Image
  Some risks are worth taking, however long the journey Academic results are part of most people’s life, whether you love them or loathe them. Most children diagnosed today with autism will do just fine at school, but this was not always the case.   Those born 20 or 30 years ago and diagnosed in early childhood with autism are usually in a much less fortunate position. Today’s post is about level 3 autism and what the Lancet Commission want to call Profound autism. The new idea is that if by age of 8, a child with autism still has severe intellectual disability or minimal language then he/she can be best described as having Profound Autism. In other literature the term SDA (Strictly Defined Autism) was proposed.   I t means what was called autism back in the 1990s and earlier. You can have severe autism with any level of IQ, which I think many people may not be aware of, or even accept.   Monty and his Academic Results The “bravo” for Monty comes from Dr Ben-A...
Read more